CareRx Corp financial statements provide useful quarterly and yearly information to potential CareRx Corp investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on CareRx Corp financial statements helps investors assess CareRx Corp's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting CareRx Corp's valuation are summarized below:
Gross Profit
108.1 M
Profit Margin
(0.01)
Market Capitalization
161.6 M
Enterprise Value Revenue
0.6378
Revenue
366.7 M
We have found one hundred twenty available fundamental signals for CareRx Corp, which can be analyzed and compared to other ratios and to its rivals. Self-guided Investors are advised to validate CareRx Corp's prevailing fundamentals against the trend between 2010 and 2025 to make sure the company can sustain itself down the road. As of the 19th of March 2025, Market Cap is likely to grow to about 91.7 M. Also, Enterprise Value is likely to grow to about 182.7 M
CareRx Corp investors utilize fundamental indicators, such as revenue or net income, to predict how CareRx Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
CareRx Corp financial ratios help investors to determine whether CareRx Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in CareRx with respect to the benefits of owning CareRx Corp security.